News

Here is the translated text in English: --- Conformat is proud to announce its participation in the International A3P Congress, a major event in the healthcare and pharmaceutical industries, held this year in Biarritz from October 8 to 10. This event brought together professionals, experts, and companies from the sector to exchange ideas, innovations, and best practices on issues related to production and quality in controlled environments.

What is the International A3P Congress?

At Conformat, we are proud to support causes that matter to us. 
Conformat supports the Rueil-Malmaison association, Les P'tits Kipik, since 2023. Our commitment is not limited to financial donations; we also provide cleaning, disinfection and personal protective equipment (PPE). These contributions are essential to help the association maintain a healthy and safe environment for hedgehogs in rehabilitation.

We are delighted to announce that Conformat has been awarded the prestigious Ecovadis Platinum label, showcasing our commitment to sustainability and corporate responsibility. At Conformat, we believe in the positive impact we can have on the world around us, and this recognition from Ecovadis validates our ongoing efforts.

We're delighted to share some news with you: we've been highlighted in a recent article in Sciences et Avenir.

The article, entitled "Conformat: le leader français de l'ultra-propreté", explores in depth our company and our ongoing commitment to innovation and cutting-edge technology. It also highlights our flagship product, KaliSafe, which is revolutionising the field of industrial safety thanks to AI.

Conformat exploits the potential of AI to intensify the protection of cleanrooms and, more generally, of protected environments.

 

The behaviour of cleanroom staff is vital to ensure not only product quality but also the safety of all. Conformat therefore offers a complete intelligent mirror solution based on AI to determine the conformity of the operator's clothing before entering the cleanroom.

By the summer of 2023, all manufacturers of sterile healthcare products (active substances, excipients, primary packaging materials and finished galenic forms) will have to comply with the new recommendations in Annex 1 of the GMP (Good Manufacturing Practices).

This revision of Annex 1 makes Quality Risk Management the pivotal element in the control of contamination, whether microbiological, particulate or chemical.

The development of single-use sterile systems, encouraged by changes in good manufacturing practice (GMP), and the fallout from the COVID crisis are leading to a significant increase in the volumes sent for sterilisation. This need is unlikely to decrease in the coming years, and is putting pressure on those involved in product sterilisation, particularly gamma irradiation sites.